Cyclacel
Investors & Media

News

All Releases
View Summary Cyclacel reports interim Phase I data for sapacitabine in patients with advanced leukemias or myelodysplastic syndromes
Nov 28, 2006
PDF 14.4 KB Add to Briefcase
View Summary Cyclacel Pharmaceuticals to present at Lazard Capital Markets Life Sciences Conference
Nov 17, 2006
PDF 11.2 KB Add to Briefcase
View Summary Cyclacel Pharmaceuticals reports third quarter 2006 financial results
Nov 13, 2006
PDF 15.8 KB Add to Briefcase
View Summary Cyclacel reports Phase I sapacitabine study results at 18th EORTC-NCI-AACR Molecular Targets and Cancer Therapeutics meeting
Nov 10, 2006
PDF 13.5 KB Add to Briefcase
View Summary Cyclacel Pharmaceuticals to announce third quarter 2006 financial results on November 13, 2006
Nov 6, 2006
PDF 11.9 KB Add to Briefcase
View Summary Cyclacel Pharmaceuticals to present at Rodman & Renshaw annual healthcare conference
Oct 30, 2006
PDF 12.1 KB Add to Briefcase
View Summary Cyclacel Pharmaceuticals to present at C.E. Unterberg, Towbin Emerging Opportunities in Healthcare Conference
Oct 24, 2006
PDF 11.3 KB Add to Briefcase
View Summary Cyclacel Pharmaceuticals names John Womelsdorf, Ph.D., Vice President, Business Development
Oct 24, 2006
PDF 12.8 KB Add to Briefcase
View Summary Cyclacel Pharmaceuticals, Inc. announces quarterly dividend for 6% Convertible Exchangeable Preferred Stock
Oct 23, 2006
PDF 10.9 KB Add to Briefcase
View Summary Cyclacel Pharmaceuticals to present at Thomson Financial and Biocentury's: NewsMakers in the Biotech Industry Conference
Sep 5, 2006
PDF 11.5 KB Add to Briefcase
View Summary Cyclacel Pharmaceuticals Reports Second Quarter 2006 Financial Results
Aug 14, 2006
PDF 12.5 KB Add to Briefcase
View Summary Cyclacel Pharmaceuticals, Inc. Announces Quarterly Dividend For 6% Convertible Exchangeable Preferred Stock
Jul 19, 2006
PDF 10.8 KB Add to Briefcase
View Summary Cyclacel Begins A Phase IIb Randomized Trial Of Seliciclib For Previously Treated Non-Small Cell Lung Cancer
Jun 29, 2006
PDF 13.0 KB Add to Briefcase
View Summary Cyclacel Begins Phase I Pharmacologic Study Of Oral Sapacitabine In Patients With Advanced Leukemias
Jun 15, 2006
PDF 13.4 KB Add to Briefcase
View Summary Cyclacel Pharmaceuticals To Present At 5th Annual Needham & Company, LLC Biotechnology & Medical Technology Conference 2006
Jun 12, 2006
PDF 10.8 KB Add to Briefcase
  Cyclacel Boosts Clinical Work With $45M Private Placement
May 18, 2006
PDF 67.7 KB Add to Briefcase
View Summary Cyclacel Pharmaceuticals To Present At Bioequity Europe 2006
May 18, 2006
PDF 10.8 KB Add to Briefcase
View Summary Cyclacel Pharmaceuticals To Present At Rodman And Renshaw 3rd Annual Global Healthcare Conference
May 4, 2006
PDF 11.2 KB Add to Briefcase
View Summary Cyclacel Pharmaceuticals Announces $45 Million Private Placement
Apr 27, 2006
PDF 12.6 KB Add to Briefcase
View Summary Cyclacel Pharmaceuticals, Inc. Announces Quarterly Dividend For 6% Convertible Exchangeable Preferred Stock
Apr 19, 2006
PDF 10.9 KB Add to Briefcase
Showing 321-340 of 344 Page: 1 ... 13 14 15 16 17 18  Previous 20 | Next 20
Add to Briefcase = add release to Briefcase
Investors & Media